Skip to main content
INGN logo

Inogen, Inc.

INGNNASDAQHealthcareMedical Devices

$7.08Today:- (-)1Y −21.34%

As of Oct 26, 2026 close

Market cap
$191.48M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$5.05$9.13
Volume (live)
-
Avg. volume (3M)
362.18K

Inogen (INGN) Income Statement

Inogen reported revenue of $348.67M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 3.9% from $335.70M a year earlier. Inogen posted a net loss of $22.75M, compared with a net loss of $35.89M a year earlier. Gross margin was 44.2% and operating margin -8.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $95.08M, up 3.0% from the same quarter a year earlier.

Inogen Income Statement Analysis

Values in millions USD

Scroll to see more
Inogen, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue348.67335.71315.66377.24358.00308.49361.94358.11249.44
Cost of Revenue194.40180.96188.96223.71181.52170.31190.08179.53128.20
Gross Profit154.27154.74126.70153.53176.48138.18171.86178.58121.24
Operating Expenses
Research & Development19.4021.6120.8421.9416.5814.089.407.035.31
Selling, General & Administrative165.07171.86182.35164.67150.67135.97142.67133.6688.33
Operating Expenses184.47197.26203.19238.78167.24150.05152.07140.6993.65
Operating Income-30.21-42.52-76.49-85.249.24-11.8719.7937.8927.59
Other Income/Expense
Interest Income4.395.196.572.840.130.914.713.260.77
Interest Expense0.000.000.000.000.000.000.000.000.00
Other Income/Expense2.446.04-32.431.98-0.58-0.064.482.562.07
Income
Income Before Tax-23.38-36.48-102.34-83.278.66-5.2824.2740.4629.66
Income Tax Expense-0.63-0.590.110.5014.990.553.32-11.398.65
Net Income-22.75-35.89-102.45-83.77-6.33-5.8320.9551.8521.00
Net Income - Continuous Operations-22.75-35.89-102.45-83.77-6.33-5.8320.9551.8521.00
Net Income - Discontinued Operations---------
EBITDA-9.55-17.73-58.34-9.5730.296.7133.6249.1939.89
EBIT-30.21-38.73-76.49-48.479.24-11.87---
Depreciation & Amortization20.6621.0018.1523.5121.6318.5813.8311.3012.30
Earnings Per Share
Basic EPS-1.00-2.00-4.00-4.00--1.002.001.00
Diluted EPS-1.00-2.00-4.00-4.00--1.002.001.00
Basic Shares Outstanding26.6023.6523.1822.8522.4921.9821.8222.5120.68
Diluted Shares Outstanding26.6023.6523.1822.8522.4921.9822.2422.5121.90

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Inogen Financial Statements

What was Inogen's revenue in fiscal 2025?

Inogen reported revenue of $348.67M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 3.9% from $335.70M a year earlier.

Is Inogen profitable?

No. Inogen reported a net loss of $22.75M in fiscal 2025. In fiscal 2024 it lost $35.89M.

What is Inogen's operating margin?

Inogen's operating income was −$30.21M on revenue of $348.67M in fiscal 2025, an operating margin of -8.7%, compared with -12.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition